OGN
Price:
$13.43
Market Cap:
$3.53B
Organon & Co., a global pharmaceutical enterprise, is dedicated to developing and delivering a wide array of prescription therapies. Its women's health division features reproductive care products, encompassing birth control and fertility treatments, notably Nexplanon/Implanon, an extended-duration contraceptive. The company's biosimilars collection includes three immune-related medications (Brenzys, Renflexis, Hadlima) and two cancer therapies (Ontruzant, Aybintio). Additionally, Organon provides cardiovascular medications, such as cholesterol-reducing drugs (Zetia, Ezetrol, Vytorin, Inegy, Rosuzet, Zocor) and treatments for high blood pressure (Cozaar, Hyzaar). Their respiratory product li...[Read more]
Industry
Drug Manufacturers - General
IPO Date
2021-05-14
Stock Exchange
NYSE
Ticker
OGN
According to Organon & Co.’s latest financial reports and current stock price. The company's current PE Ratio is 14.44. This represents a change of 539.43% compared to the average of 2.26 of the last 4 quarters.
The mean historical PE Ratio of Organon & Co. over the last ten years is 5.17. The current 14.44 PE Ratio has changed 27.82% with respect to the historical average. Over the past ten years (40 quarters), OGN's PE Ratio was at its highest in in the September 2023 quarter at 18.87. The PE Ratio was at its lowest in in the December 2025 quarter at -2.27.
Average
5.17
Median
4.44
Minimum
2.62
Maximum
9.96
Discovering the peaks and valleys of Organon & Co. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 124.26%
Maximum Annual PE Ratio = 9.96
Minimum Annual Increase = -53.52%
Minimum Annual PE Ratio = 2.62
| Year | PE Ratio | Change |
|---|---|---|
| 2025 | 9.96 | 124.26% |
| 2024 | 4.44 | 23.48% |
| 2023 | 3.60 | -53.52% |
| 2022 | 7.74 | 35.43% |
| 2021 | 5.71 | 46.39% |
| 2020 | 3.90 | 49.18% |
| 2019 | 2.62 | -33.04% |
| 2018 | 3.91 | -16.45% |
The current PE Ratio of Organon & Co. (OGN) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
6.00
5-year avg
6.29
10-year avg
5.17
Organon & Co.’s PE Ratio is greater than Phibro Animal Health Corporation (13.61), greater than Aurinia Pharmaceuticals Inc. (7.35), greater than Nuvation Bio Inc. (-13.10), less than Avadel Pharmaceuticals plc (108.20K), greater than Tilray Brands, Inc. (-0.25), greater than Harmony Biosciences Holdings, Inc. (13.21), greater than Pediatrix Medical Group, Inc. (11.46), less than Guardian Pharmacy Services, Inc. (49.89), less than Select Medical Holdings Corporation (15.17), greater than Alvotech (-13.79),
| Company | PE Ratio | Market cap |
|---|---|---|
| 13.61 | $1.29B | |
| 7.35 | $2.12B | |
| -13.10 | $1.93B | |
| 108.20K | $2.12B | |
| -0.25 | $565.73M | |
| 13.21 | $1.93B | |
| 11.46 | $1.94B | |
| 49.89 | $2.69B | |
| 15.17 | $2.05B | |
| -13.79 | $1.22B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Organon & Co. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Organon & Co. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Organon & Co.'s PE Ratio?
How is the PE Ratio calculated for Organon & Co. (OGN)?
What is the highest PE Ratio for Organon & Co. (OGN)?
What is the 3-year average PE Ratio for Organon & Co. (OGN)?
What is the 5-year average PE Ratio for Organon & Co. (OGN)?
How does the current PE Ratio for Organon & Co. (OGN) compare to its historical average?